Dyne Therapeutics, Inc. · NASDAQ:DYN
Point72 Asset Management, L.P.'s stake in Dyne Therapeutics, Inc. fell to 1.50% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Point72 Asset Management, L.P.'s stake in Dyne Therapeutics, Inc. fell to 1.50%, 1,669,342 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 1.50%
- Shares
- 1,669,342
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 1.50% | 1,669,342 |
| Point72 Capital Advisors, Inc. | 1.50% | 1,669,342 |
| Steven A. Cohen | 1.50% | 1,669,342 |
Source
Related
- Dyne Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Dyne Therapeutics, Inc. shareholders
- Schedule 13G · Point72 Asset Management, L.P. · Feb 3, 2025
- Form 4 · Kerr Douglas · Oct 22, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026